1. Background
Fibromyalgia (FM) is a chronic condition defined by widespread pain, fatigue, and a range of distressing sensory symptoms, including tactile allodynia (pain from light touch) and thermal dysaesthesia (unpleasant sensations from temperature changes). While research has established a connection between these symptoms and neuropathy of small nerves, the contribution of larger diameter sensory nerves fibres is not well understood. This has created a critical knowledge gap, particularly concerning the mechanisms that drive abnormal sensations of touch and cold in people with FM.
2. Study Aims and Objectives
This study was designed to investigate this gap and determine the role of large sensory fibres in the sensory abnormalities experienced by people living with FM.
The primary strategic aim of this research was to determine if a link existed between Immunoglobulin G (IgG) autoantibodies taken from people with FM and the sensitization of large diameter nerve fibres, known as Aβ low-threshold mechanoreceptors (Aβ-LTMRs). These are a subgroup of nerve fibres responsible for detecting light touch.
To achieve this, the study pursued several key objectives:
- To test whether the passive transfer of IgG from people with FM to mice could induce sensitivity to light touch and mild cold.
- To examine the changes in mouse Aβ-LTMRs nerve cells.
- To assess Aβ-LTMR function in people with FM.
These objectives were designed to build a case for an autoimmune mechanism being an important part of FM.
3. Study Findings and Conclusions
The study’s findings provided strong evidence for an autoimmune mechanism driving sensory abnormalities in FM.
The transfer of IgG from FM patients to mice induced hypersensitivity to light touch from a cotton bud. This behavioural change was strongly associated with measurable changes at the cellular level. Aβ-LTMRs nerve cells became more responsive to touch but also became sensitive to cold—a unusal function this type of cell. This is very similar to the heightened sensitivity to touch and cold reported by some people with FM. Direct nerve measurements in people found the same changes in sensitivity within the same AβSA fibre population.
The overarching conclusion from this multi-modal investigation is that IgG autoantibodies are a driver of large sensory nerve dysfunction in FM.
4. Recommendations to Researchers and Healthcare Professionals
The implications of this study that FM might be a condition with a clear autoimmune component, opening new avenues for diagnostics and therapeutic development.
This research validates a biological basis of patient-reported FM sensory symptoms. Clinicians should recognize that complaints of tingling, numbness, and pain from light touch may be linked to changes in the nerves of their patients.
Further studies are required to clarify these specific pathways in people with FM. However, there is scope for new clinical trials to try and help people with FM.